SCHEMBL8058346

SCHEMBL8058346

CC=C(C(=O)O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.57
NR4A1 P22736 1/20 0.56
NR4A2 P43354 1/20 0.56
NR4A3 Q92570 1/20 0.56
CES2 O00748 2/20 0.55
CES1 P23141 2/20 0.55
SRD5A2 P31213 2/20 0.53
PTPN1 P18031 2/20 0.51
CYP1A1 P04798 2/20 0.47
CYP1B1 Q16678 2/20 0.47
MAOB P27338 1/20 0.47
GSK3B P49841 2/20 0.47
TRPV1 Q8NER1 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
CYP1A2 P05177 1/20 0.43
ALDH1A1 P00352 1/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888007 0.84 AKR1C3 (0.54) AKR1C3NR4A1NR4A2NR4A3CES2
SCHEMBL8958863 0.82 AKR1C3 (0.52) AKR1C3NR4A1NR4A2NR4A3CES2
SCHEMBL8958858 0.82 AKR1C3 (0.52) AKR1C3NR4A1NR4A2NR4A3CES2
SCHEMBL10584486 0.80 CES2 (0.50) AKR1C3NR4A1NR4A2NR4A3CES2
SCHEMBL8047995 0.80 CES2 (0.50) AKR1C3NR4A1NR4A2NR4A3CES2
SCHEMBL7942173 0.78 ALDH1A1 (0.56) AKR1C3CES2CES1PTPN1NPC1
SCHEMBL3563640 0.77 CYP1A1 (0.61) NR4A1NR4A2NR4A3CES2CES1
SCHEMBL3563636 0.77 CYP1A1 (0.61) NR4A1NR4A2NR4A3CES2CES1
SCHEMBL28550534 0.76 AKR1C3 (0.68) AKR1C3CES2CES1SRD5A2CYP1A1
SCHEMBL7228800 0.76 CES2 (0.59) NR4A1NR4A2NR4A3CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
EP-1003712-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-05-31 EP disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed
WO-1999007669-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-02-18 WO disclosed